|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROSCIENCE |
1 Division of Cerebral Structure, National Institute for Physiological Sciences, Okazaki 444-8787, Japan
2 Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Kawaguchi, Japan
Whole-cell patch-clamp recordings of non-NMDA glutamatergic EPSCs were made from identified cholinergic neurones in slices of basal forebrain (BF) of young rats (P13P18), to investigate the subtypes of calcium channels involved in dopamine D1-like receptor-mediated presynaptic inhibition of the EPSCs. The BF cholinergic neurones were pre-labelled by intracerebroventricular injection of a fluorescent marker, Cy3-192IgG. A D1-like receptor agonist, SKF 81297 (30 µM) suppressed the EPSCs reversibly by about 30%, and this inhibition was reproducible. Calcium channel subtypes involved in the glutamatergic transmission were elucidated using selective Ca2+ channel blockers. The N-type Ca2+ channel blocker
-conotoxin (
-CgTX, 3 µM) suppressed the EPSCs by 57.5%, whereas the P/Q-type channel selective blocker
-agatoxin-TK (
-Aga-TK, 200 nM) suppressed the EPSCs by 68.9%. Simultaneous application of both blockers suppressed the EPSCs by 96.1%. The R-type Ca2+ channel blocker SNX-482 (300 nM) suppressed the EPSCs by 18.4%, whereas nifedipine, the L-type Ca2+ channel blocker (10 µM), had little effect. In the presence of
-Aga-TK, SKF 81297, a dopamine D1-like receptor agonist, had no effect on the EPSCs. On the other hand, SKF 81297 could still inhibit the EPSCs in the presence of either
-CgTX, SNX-482 or nifedipine. SKF 81297 had no further effect on the EPSCs when external Ca2+ concentration was raised to 7.2 mM in the presence of
-Aga-TK, but could still inhibit the EPSCs in high Ca2+ solution after
-CgTX application. Forskolin (FK, 10 µM), an activator of adenylyl cyclase pathway, suppressed the EPSCs, and the FK-induced effect was mostly blocked in the presence of
-Aga-TK but not that of
-CgTX. These results suggest that D1-like receptor activation selectively blocks P/Q-type calcium channels to reduce glutamate release onto BF cholinergic neurones.
(Received 28 November 2006;
accepted after revision 11 January 2007;
first published online 18 January 2007)
Corresponding author T. Momiyama: Division of Cerebral Structure, National Institute for Physiological Sciences, Okazaki 444-8787, Japan. Email: tmomi{at}nips.ac.jp
This article has been cited by other articles:
![]() |
S. K. Towers and S. Hestrin D1-Like Dopamine Receptor Activation Modulates GABAergic Inhibition But Not Electrical Coupling between Neocortical Fast-Spiking Interneurons J. Neurosci., March 5, 2008; 28(10): 2633 - 2641. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Nimmrich, C. Grimm, A. Draguhn, S. Barghorn, A. Lehmann, H. Schoemaker, H. Hillen, G. Gross, U. Ebert, and C. Bruehl Amyloid {beta} Oligomers (A{beta}1-42 Globulomer) Suppress Spontaneous Synaptic Activity by Inhibition of P/Q-Type Calcium Currents J. Neurosci., January 23, 2008; 28(4): 788 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Chin, L. Ma, D. MacTavish, and J. H. Jhamandas Amyloid {beta} Protein Modulates Glutamate-Mediated Neurotransmission in the Rat Basal Forebrain: Involvement of Presynaptic Neuronal Nicotinic Acetylcholine and Metabotropic Glutamate Receptors J. Neurosci., August 29, 2007; 27(35): 9262 - 9269. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |